APB to Proceed with IPO Despite Market Conditions, ABI Warning | GenomeWeb

NEW YORK, March 22 – Nycomed Amersham is continuing with its plans to launch an initial public offering of shares in its subsidiary Amersham Pharmacia Biotech on the Nasdaq this spring, despite the downturn in the economy and a warning from competitor Applied Biosystems, the company said Thursday.

“As far as the IPO goes, we continue to work through the normal process with the SEC in filing our registration statement,” Tracy Cheung, vice president of investor relations at AP Biotech, told GenomeWeb.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."